The search for new candidate genes involved in ovarian cancer pathogenesis by exome sequencing
Authors:
- D. S. ProkofyevaDPD. S. Prokofyeva
- E. T. MingajevaEME. T. Mingajeva
- N. V. BogdanovaNBN. V. Bogdanova
- R. R. FaiskhanovaRFR. R. Faiskhanova
- D. D. SakaevaDSD. D. Sakaeva
- T. DörkTDT. Dörk
- 20 October 2016
- journal article
- Published by Pleiades Publishing Ltd in Russian Journal of Genetics
- Vol. 52 (10) , 1105-1109
Abstract
Ovarian cancer is one of the most insidious of tumors among gynecological cancers in the world. BRCA1 and BRCA2 mutations are associated with high risk of ovarian cancer; however, they are causative only in a fraction of cases. The search for new genes would expand our understanding of the mechanisms underlying malignant ovarian tumors and could help to develop new methods of early diagnosis and treatment of the disease. The present study involved exome sequencing of eight DNA samples extracted from the blood of ovarian cancer patients. As a result of the study, 53057 modifications in one sample were identified on average. Of them, 222 nucleotide sequence modifications in DNA located in exons and splice sites of 203 genes were selected. On the basis of the function of these genes in the cell and their involvement in carcinogenesis, 40 novel candidate genes were selected. These genes are involved in cell cycle control, DNA repair, apoptosis, regulation of cell invasion, proliferation and growth, transcription, and also immune response and might be involved in development of ovarian cancer.Keywords
This publication has 12 references indexed in Scilit:
- The role of MMP-1 in breast cancer growth and metastasis to the brain in a xenograft modelBMC Cancer, 2012
- dbNSFP: A lightweight database of human nonsynonymous SNPs and their functional predictionsHuman Mutation, 2011
- A window into third-generation sequencingHuman Molecular Genetics, 2010
- ANNOVAR: functional annotation of genetic variants from high-throughput sequencing dataNucleic Acids Research, 2010
- REV3L confers chemoresistance to cisplatin in human gliomas: The potential of its RNAi for synergistic therapyNeuro-Oncology, 2009
- CXCR3 expression is associated with poor survival in breast cancer and promotes metastasis in a murine modelMolecular Cancer Therapeutics, 2009
- The Contribution of BRCA1 and BRCA2 to Ovarian CancerMolecular Oncology, 2009
- Frequent expression loss of Inter-alpha-trypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors: A systematic expression analysisBMC Cancer, 2008
- Interaction between Mnk2 and CBCVHL ubiquitin ligase E3 complexScience China Life Sciences, 2006
- MRP9, an unusual truncated member of the ABC transporter superfamily, is highly expressed in breast cancerProceedings of the National Academy of Sciences, 2002